Updated from 7:03 a.m. EDT

What a difference a week can make! The S&P 500 gained 10% in what was the strongest week on Wall Street since November.

Friday was a good day for health care stocks, with Merck ( MRK) gaining 14% after being upgraded by an analyst. The blue-chip drug manufacturer got a boost on new drug trial data out from Schering-Plough ( SGP), a company it is trying to acquire. Other big health care movers included Johnson & Johnson ( JNJ) and Pfizer ( PFE).

Despite the big move in the markets this week, investors still want to know if we've seen the bottom. Will the market continue to recover?

With this in mind, we thought we'd take a look at some of the stocks people have been searching for on TheStreet.com (including Goldman Sachs ( GS)) and see what Jim Cramer's had to say from them lately.

To read more, visit Stockpickr.com.

In Monday trading, shares of Goldman Sachs closed at $93.90 (down 4.96% for the day; up 3.1% for the month).
Stockpickr is a wholly owned subsidiary of TheStreet.com.

If you liked this article you might like

China's Banks Halt Business With North Korea Per United Nations Sanctions

Why Hurricanes Won't Force the Fed to Ditch a December Rate Hike

Fed Pares $4.5 Trillion Balance Sheet But Easy-Money Era Isn't Over

Bank Stocks Move Higher as Fed Decides to Start Unwinding Balance Sheet

Cramer: Goldman's Downgrade Of J&J Is 'Questionable'